James Li’s Publications

  1. Day TF, Mewani RR, Starr J, Li X, Chakravarty D, Ressom H, Zou X, Eidelman O, Pollard HB, Srivastava M, Kasid UN. “Transcriptome and Proteome Analyses of TNFAIP8 Knockdown Cancer Cells Reveal New Insights into Molecular Determinants of Cell Survival and Tumor Progression.” Methods Mol Biol. 1513:83-100. PMID: 27807832 (2017)
  2. Su X, Fischer DL, Li X, Bankiewicz K, Sortwell CE, Federoff HJ. “Alpha-Synuclein mRNA Is Not Increased.” Molecular Therapy (2017)
  3. Chen Y, Li X, Kobayashi I, Tsao D, Mellman TA. “Expression and methylation in posttraumatic stress disorder and resilience; evidence of a role for odorant receptors.” Psychiatry Res. 245:36-44. (2016).
  4. Dakic A, DiVito K, Fang S, Suprynowicz F, Gaur A, Li X, Palechor-Ceron N, Simic V, Choudhury S, Yu S, Simbulan-Rosenthal CM, Rosenthal D, Schlegel R, Liu X. “ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes.” Oncotarget. doi: 10.18632/oncotarget.11458. (2016).
  5. Do Canto LM, Marian C, Willey S, Sidawy M, Da Cunha PA, Rone JD, Li X, Gusev Y, Haddad BR.  “MicroRNA analysis of breast ductal fluid in breast cancer patients.” International Journal of Oncology (2016).
  6. Celik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong SH, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A. “Ezrin Inhibition Upregulates Stress Response Gene Expression.” Journal of Biological Chemistry (2016).
  7. Li X, Scheich B. “Predicting Tumor Stages of Lung Cancer Adenocarcinoma Tumors from Pooled Microarray Data using Machine Learning Methods.” International Journal of Computational Biology and Drug Design (2015).
  8. Iyalomhe O, Chen Y, Allard J, Ntekim O, Johnson S, Bond V, Goerlitz D,  Li J, Obisesan TO. “A standardized randomized 6-month aerobic exercise-training down-regulated pro-inflammatory genes, but up-regulated anti-inflammatory, neuron survival and axon growth-related genes.” Experimental Gerotology (2015).
  9. Artym VV, Swatkoski S, Matsumoto K, Campbell CB, Petrie RJ, Dimitriadis EK, Li X, Mueller S, Bugge TH, Gucek M, Yamada KM. “Dense fibrillar collagen is a potent inducer of invadopodia via a specific signaling network.” Journal of Cell Biology 208.3 (2015): 331-350.
  10. Li H, Li X, Smerin S.E., Zhang L, Jia M, Xing G, Su Y.A., Wen J, Benedek D, Ursano R. “Mitochondrial gene expression profiles and metabolic pathways in the amygdala associated with exaggerated fear in an animal model of PTSD.” Frontiers in Neurology (2014).

  1. Shah N, Wang J, Selich-Anderson J, Graham G, Siddiqui H, Li X, Khan J, Toretsky J. “PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13-cis Retinoic AcidMediated Differentiation in Neuroblastoma.” Clinical Cancer Research 20.16 (2014): 4400-12.
  2. Srivastava A, Goldberger H, Dimtchev A, Marian C, Soldin O, Li X, Collins SP, Suy S, Kumar D. “Circulatory miR-628-5p is downregulated in prostate cancer patients.” Tumor Biology (2014).
  3. Pollock CB, McDonough S, Wang VS, Lee H, Ringer L, Li X, Prandi C, Lee RJ, Feldman AS, Koltai H, Kapulnik Y, Rodriguez OC, Schlegel R, Albanese C, Yarden RI “Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells.” Oncotarget. 5(6):1683-98. (2014)
  4. Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann E, Uhm S, Kim J S, Chen L N, Li X, Berry D L, Kallakury B V S, Chauhan S C, Collins S P, Suy S, Kumar D. “MicroRNA Profiling in Prostate Cancer – The Diagnostic Potential of Urinary miR-205 and miR-214.” PLoS One 8.10 (2013): e76994.
  5. Sun N, Li D, Fonzi W, Li X, Zhang L, Calderone R. “Multidrug Resistant Transporter Mdr1p Mediated Uptake of a Novel Antifungal Compound.” Antimicrobial Agents and Chemotherapy (2013).
  6. Karve, T., Li, X., Saha, T. (2012). A Functional Genomics Approach to Identify BRCA1-mediated Signaling Pathways in Ovarian Carcinogenesis. Functional and Integrative Genomics,12(1), 63-79.
  7. Upadhyay, G., Yin, Y., Yuan, H., Li, X., Derynck, R., Glazer, R.I. (2011). Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)–dependent TGF-β signaling. Proceedings of the National Academy of Sciences of the United States of America (PNAS). 108(19), 7820-7825.
  8. Pollock, C. B., Yin, Y., Yuan, H., Zeng, X., King, S., Li, X., Kopelovich, L., Albanese, C., & Glazer, R.I. (2011). PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis, PLoS ONE, 6(1), 12.
  9. Li, X. (2010). Privacy Preserving Clustering for Distributed Homogeneous Gene Expression Datasets. International Journal of Computational Models and Algorithms in Medicine (IJCMAM),1(3), 31-54.
  10. Pollock, C.B., Rodriguez, O., Martin, P.L., Albanese, C., Li, X., Kopelovich, L., & Glazer, R.I. (2010). Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation. PPAR Research, 2010, 8.
  11. Liu, H., Bebu, I., & Li, X. (2010). Microarray probes and probe sets. Front Biosci, 325-28.